SABCS 2018: Circulating tumour cell count could help choose treatment for metastatic breast cancer patients
Circulating tumour-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline…
Circulating tumour-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline…
Patients with early-stage breast cancer who had cancer detected in a sentinel lymph node biopsy…
Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival…
Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had…
Survivors of early-stage breast cancer who participated in a lifestyle intervention on healthy habits lost…
Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who…
Even as more young women with breast cancer opt to have mastectomies, many experience a…
Women who underwent a supervised program of cardiovascular exercise during adjuvant breast cancer treatment experienced…
In a new study presented at ASH 2018 in San Diego, patients with ALL who received a…
A new study presented at ASH 2018 shows older patients with chronic lymphocytic leukaemia (CLL) have a…